The co-occurrence of TDP-43 and alpha-synuclein pathologies in the amygdala represents a significant pathological intersection in neurodegenerative diseases. This hypothesis posits that these proteinopathies often represent downstream or secondary effects in brains with advanced Alzheimer's disease pathology rather than independent primary disease processes 1. Understanding this relationship is crucial for developing targeted therapeutic interventions and accurate diagnostic frameworks. [1]
The co-occurrence of TDP-43 and alpha-synuclein pathologies in the amygdala is supported by multiple postmortem studies, but the causal relationship remains uncertain. The evidence suggests these proteinopathies are frequently comorbid rather than causally linked.
| Type | Evidence |
|---|---|
| Genetic | C9orf72 expansions cause both TDP-43 and alpha-synuclein pathology [2]; TBK1 mutations link ALS/FTD with synucleinopathies [3] |
| Clinical | Amygdala co-pathology correlates with more severe neuropsychiatric symptoms [4] |
| Neuropathological | SEA-AD data shows 40-60% of AD brains have amygdala TDP-43 [5]; Alpha-synuclein in 30-50% of TDP-43 cases [6] |
| Experimental | Cross-seeding demonstrated in cell and animal models [7] |
| Computational | Protein interaction network analysis predicts TDP-43/α-syn synergy |
The hypothesis can be tested through:
Common therapeutic targets: autophagy enhancement, RNA processing modifiers, protein clearance
TAR DNA-binding protein 43 (TDP-43) is a nuclear protein involved in RNA metabolism, splicing, and transport. In neurodegenerative diseases, TDP-43 accumulates in the cytoplasm as insoluble inclusions, a pathology observed in: [8]
Alpha-synuclein is a presynaptic protein involved in neurotransmitter release. Its misfolding and aggregation into Lewy bodies characterizes: [9]
| Entity | Role | Wiki Link |
|---|---|---|
| TDP-43 | RNA-binding protein, forms cytoplasmic inclusions | TDP-43 Protein |
| Alpha-synuclein | Synuclein family, forms Lewy bodies | Alpha-Synuclein |
| TARDBP (TDP-43 gene) | Encodes TDP-43 protein | TARDBP Gene |
| SNCA (α-syn gene) | Encodes alpha-synuclein | SNCA Gene |
| C9orf72 | Hexanucleotide expansion causes both pathologies | C9orf72 Gene |
| TBK1 | Kinase mutations link ALS/FTD with synucleinopathies | TBK1 Gene |
| OPTN | Autophagy receptor in TDP-43 pathology | OPTN Gene |
| mTOR | Dysregulated in TDP-43 proteinopathy | mTOR Protein |
| FUS | RNA-binding protein, ALS/FTD mutations | FUS Gene |
| TIA1 | Stress granule component, TDP-43 pathology | TIA1 Gene |
| p62 | Autophagy receptor, aggregates in TDP-43 | SQSTM1 Gene |
| UBQLN2 | Ubiquitin-binding protein in inclusions | UBQLN2 Gene |
The amygdala is particularly vulnerable to multiple proteinopathies due to: [10]
Research from the Seattle-Alzheimer's Disease Brain Cell Atlas (SEA-AD) has revealed 1: [11]
Amygdala pathology in neurodegenerative diseases (Nature Reviews Neurology). ↩︎
C9orf72 hexanucleotide expansion in ALS/FTD (Lancet Neurology). ↩︎
Amygdala co-pathology patterns in neurodegenerative disease (Brain 2023). ↩︎
LATE-NC prevalence and staging (Acta Neuropathologica 2024). ↩︎
Alpha-synuclein and TDP-43 co-pathology in the amygdala (Brain). ↩︎
Alpha-synuclein seeding in TDP-43 proteinopathy (Acta Neuropathologica 2024). ↩︎
TDP-43 pathology in Alzheimer's disease (Acta Neuropathologica). ↩︎
LATE-NC: Limbic-predominant age-related TDP-43 encephalopathy (Brain). ↩︎
Autophagy impairment in TDP-43 proteinopathy (Autophagy 2024). ↩︎